Life360 director-linked trust sells 4,000 shares
Life360 director John Philip Coghlan, through the John Coghlan Living Trust, reported open-market sales of 4,000 shares of common stock on March 9, 2026.
Rhea-AI Filing Summary
Life360 director John Philip Coghlan, through the John Coghlan Living Trust, reported open-market sales of 4,000 shares of common stock on March 9, 2026. The shares were sold in two trades at weighted average prices of $45.29 and $46.56 per share.
The sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 8, 2025, meaning they were scheduled in advance. After these transactions, the trust held 5,065 shares, while Coghlan also held 36,202 shares directly and 55,494 shares indirectly through a separate grantor retained annuity trust, including 836 restricted stock units.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common stock | 1,242 | $45.29 | $56K |
| Sale | Common stock | 2,758 | $46.56 | $128K |
| holding | Common stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (4)
- F1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2025. The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of the Issuer's common stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company.
- F2. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $44.75 to $45.70, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
- F3. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $45.95 to $46.85, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
- F4. Includes 836 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
AI-generated analysis. How Rhea-AI works. Not financial advice.